Alnefaie Majed, Alamri Abdullah, Saeedi Asalh, Althobaiti Awwadh, Alosaimi Shahad, Alqurashi Yousuf, Marzouki Hani, Merdad Mazin
King Fahad Armed Forces Hospital, Medical Services of The Armed Forces, Jeddah, Saudi Arabia.
Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Interact J Med Res. 2022 Mar 18;11(1):e24592. doi: 10.2196/24592.
With respect to patients with head and neck squamous cell carcinoma (HNSCC), posttreatment surveillance for distant disease has mostly focused on the lungs, as HNSCC distant metastasis occurs in this organ in 90% of HNSCC cases. Additionally, the incidence rate of primary tumors in the lungs is high due to the field cancerization of the entire upper aerodigestive tract.
Our cross-sectional survey study aims to evaluate the current beliefs and pulmonary screening practices of otolaryngology-head and neck surgeons across Saudi Arabia with respect to the posttreatment surveillance of HNSCC.
This nationwide cross-sectional survey was conducted among head and neck surgeon members of the Saudi Society of Otolaryngology from June 1 to June 30, 2020. A predesigned questionnaire was used for data collection, and a descriptive analysis was carried out.
This study included 22 participants and had a 78% (22/28) response rate. This study found that the majority of participants (9/22, 41%) used lung radiography for routine lung screening during posttreatment follow-ups, whereas 32% (7/22) used low-dose computed tomography (CT; 7/22, 32%). With regard to the number of years for which participants perform lung screening during follow-ups, the majority of participants (17/22, 77%) reported 5 years, and only 9% (2/22) have performed lifelong lung screening. With regard to the frequency of lung screening, 77% (17/22) of participants conduct screening annually, 18% (4/22) conduct screening half-yearly, and 5% (1/22) conduct screening biennially. With regard to beliefs about the effectiveness of screening procedures in reducing lung cancer mortality rates during follow-ups, 36% (8/22) of participants believed them to be very effective or somewhat effective, 18% (4/22) did not know, and only 9% (2/22) believed that they were not effective.
The participants mainly used lung radiography (9/22, 41%), low-dose CT (7/22, 32%), or positron emission tomography/CT (6/22, 27%) as a routine lung screening method during the posttreatment follow-up of patients with head and neck cancer for 5 years (17/22, 77%) or 10 years (3/22, 14%), and only a small percentage of participants have performed lifelong lung screening (2/22, 9%). Lung screening was mostly conducted annually or half-yearly. Such screening was believed to be very effective or somewhat effective.
对于头颈部鳞状细胞癌（HNSCC）患者，远处疾病的治疗后监测主要集中在肺部，因为90%的HNSCC病例发生远处转移的器官是肺部。此外，由于整个上呼吸道消化道的场癌化，肺部原发性肿瘤的发病率很高。
我们的横断面调查研究旨在评估沙特阿拉伯各地耳鼻喉科-头颈外科医生对HNSCC治疗后监测的当前看法和肺部筛查实践。
2020年6月1日至6月30日，对沙特耳鼻喉科协会的头颈外科医生成员进行了这项全国性横断面调查。使用预先设计的问卷收集数据，并进行描述性分析。
本研究纳入了22名参与者，回复率为78%（22/28）。研究发现，大多数参与者（9/22，41%）在治疗后随访期间使用肺部X光进行常规肺部筛查，而32%（7/22）使用低剂量计算机断层扫描（CT；7/22，32%）。关于参与者在随访期间进行肺部筛查的年数，大多数参与者（17/22，77%）报告为5年，只有9%（2/22）进行终身肺部筛查。关于肺部筛查的频率，77%（17/22）的参与者每年进行筛查，18%（4/22）每半年进行筛查，5%（1/22）每两年进行筛查。关于对筛查程序在随访期间降低肺癌死亡率有效性的看法，36%（8/22）的参与者认为非常有效或有点有效，18%（4/22）不知道，只有9%（2/22）认为无效。
参与者在头颈部癌症患者治疗后随访期间主要使用肺部X光（9/22，41%）、低剂量CT（7/22，32%）或正电子发射断层扫描/CT（6/22，27%）作为常规肺部筛查方法，持续5年（17/22，77%）或10年（3/22，14%），只有一小部分参与者进行终身肺部筛查（2/22，9%）。肺部筛查大多每年或每半年进行一次。这种筛查被认为非常有效或有点有效。
